CLINICAL TRIAL / IRB20-0087

  • Recruiting
Eligibility Details Visit Clinicaltrials.gov

Contact Information

10 Similar Clinical Trials

AN OBSERVATIONAL STUDY OF OCRELIZUMAB TREATED PATIENTS WITH MULTIPLE SCLEROSIS TO DETERMINE THE INCIDENCE AND MORTALITY RATES OF BREAST CANCER AND ALL MALIGNANCIES (VERISMO STUDY)

Gender
Any

Age Group
Any

At a Glance

IRB#IRB20-0087

Lead PhysicianAnthony T. Reder

Collaborator(s)N/A

EligibilityRecruiting